The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats
- PMID: 10051187
- DOI: 10.1016/s0306-4522(98)00175-4
The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats
Abstract
Neuroleptic-induced oral dyskinesias in rats, a putative analogue to human tardive dyskinesia, may be due to excitotoxic degeneration within the striatum. Haloperidol treatment for 34 weeks increased the optical density of preproenkephalin messenger RNA in individual striatal neurons and enkephalin peptide in the neuropil, regardless of the level of oral dyskinesia produced. However, using unbiased stereological methods, an increased number of striatal neurons expressing preproenkephalin messenger RNA was observed only in rats that did not develop pronounced oral dyskinesias during haloperidol treatment. Said in another manner, the haloperidol-treated animals that developed pronounced oral dyskinesias, failed to produce an increase in the number of neurons expressing preproenkephalin messenger RNA. These results indicate that the mechanism by which neuroleptics induce oral dyskinesias in rats, and perhaps tardive dyskinesia in humans, involves a functional disturbance or even damage to a subpopulation of enkephalinergic neurons in the striatum.
Similar articles
-
Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration.Neurosci Lett. 2000 Jan 21;279(1):21-4. doi: 10.1016/s0304-3940(99)00939-8. Neurosci Lett. 2000. PMID: 10670778
-
Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats.Brain Res. 2003 Dec 24;994(2):188-92. doi: 10.1016/j.brainres.2003.09.035. Brain Res. 2003. PMID: 14642644
-
Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.Neuroscience. 1998 Dec;87(3):639-48. doi: 10.1016/s0306-4522(98)00160-2. Neuroscience. 1998. PMID: 9758230
-
Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?Prog Neurobiol. 2000 Aug;61(5):525-41. doi: 10.1016/s0301-0082(99)00064-7. Prog Neurobiol. 2000. PMID: 10748322 Review.
-
Gene memory in neuroendocrine and behavioural systems.Ciba Found Symp. 1992;168:165-83; discussion 183-6. doi: 10.1002/9780470514283.ch11. Ciba Found Symp. 1992. PMID: 1425024 Review.
Cited by
-
[Antipsychotic-induced tardive syndromes].Neuropsychiatr. 2016 Sep;30(3):123-130. doi: 10.1007/s40211-016-0189-7. Epub 2016 Aug 31. Neuropsychiatr. 2016. PMID: 27580887 Review. German.
-
Tardive and idiopathic oromandibular dystonia: a clinical comparison.J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):186-90. doi: 10.1136/jnnp.68.2.186. J Neurol Neurosurg Psychiatry. 2000. PMID: 10644785 Free PMC article.
-
Effect of chronic treatment of haloperidol on the rat liver: a stereological and histopathological study.Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):253-61. doi: 10.1007/s00210-008-0362-z. Epub 2008 Oct 21. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18936913
-
Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.Psychopharmacology (Berl). 2003 Aug;169(1):28-34. doi: 10.1007/s00213-003-1466-2. Epub 2003 Jun 27. Psychopharmacology (Berl). 2003. PMID: 12830366
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources